Nachman Norwood & Parrott’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $3.11M | Sell |
27,606
-17
| -0.1% | -$1.92K | 0.32% | 68 |
|
|
2021
Q1 | $2.99M | Buy |
27,623
+96
| +0.3% | +$10.4K | 0.33% | 64 |
|
|
2020
Q4 | $2.95M | Buy |
27,527
+845
| +3% | +$90.5K | 0.34% | 59 |
|
|
2020
Q3 | $2.34M | Sell |
26,682
-245
| -0.9% | -$21.5K | 0.31% | 69 |
|
|
2020
Q2 | $2.64M | Buy |
26,927
+3,770
| +16% | +$370K | 0.44% | 49 |
|
|
2020
Q1 | $1.76M | Buy |
23,157
+1,632
| +8% | +$124K | 0.36% | 68 |
|
|
2019
Q4 | $1.91M | Buy |
21,525
+711
| +3% | +$63K | 0.31% | 68 |
|
|
2019
Q3 | $1.58M | Buy |
20,814
+301
| +1% | +$22.8K | 0.28% | 74 |
|
|
2019
Q2 | $1.49M | Buy |
20,513
+334
| +2% | +$24.3K | 0.27% | 74 |
|
|
2019
Q1 | $1.63M | Buy |
20,179
+376
| +2% | +$30.3K | 0.3% | 75 |
|
|
2018
Q4 | $1.83M | Buy |
+19,803
| New | +$1.83M | 0.38% | 62 |
|